The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2018

Filed:

Jan. 14, 2014
Applicants:

Dcb-usa Llc, Wilmington, DE (US);

National Taiwan University, Taipei, TW;

Academia Sinica, Taipei, TW;

Inventors:

Pan-Chyr Yang, Taipei, TW;

Wei-Yun Lai, Taipei, TW;

Konan Peck, Taipei, TW;

Cheng-Ju Chang, Taipei, TW;

Chi-Yuan Chen, Taipei, TW;

Shuenn-Chen Yang, Taipei, TW;

Assignees:

National Taiwan University, Taipei, TW;

ACADEMIA SINICA, Taipei, TW;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/11 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); C07K 14/485 (2006.01); A61K 31/517 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61K 31/517 (2013.01); A61K 31/713 (2013.01); C07K 14/485 (2013.01); C12N 2310/127 (2013.01); C12N 2310/315 (2013.01); C12N 2310/33 (2013.01); C12N 2310/3515 (2013.01); C12N 2320/31 (2013.01); C12N 2320/34 (2013.01);
Abstract

The invention provides DNAzymes which are capable to silence the expression of EGFR at allele-specific level. These allele-specific DNAzymes against EGFR T790M mutation will knockdown the expression of EGFR T790M mRNA while keeping EGFR wild-type mRNA intact. Hence, these allele-specific DNAzymes against EGFR T790M mutation may overcome T790M-derived TKI resistance accompanied with lower unwanted side effects on normal cells in lung cancer patients.


Find Patent Forward Citations

Loading…